'My Type 1 Info' is a brand new resource available for children and young people with type 1 diabetes to use in school.

Save for later Page saved! You can go back to this later in your Diabetes and Me Close ...

Together Type 1 is a UK-wide youth programme funded by the Steve Morgan Foundation and run by us. We understand that living with type 1 diabetes can be hard - at times it can be frustrating, ...

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

Causes of type 1 diabetes It’s normal to wonder if something you’ve done could have caused your type 1 diabetes – or a child’s type 1 diabetes. But there’s nothing you could have done to prevent it.

Scientists in the United States have announced early results from a pioneering trial testing a new stem cell treatment designed to replace insulin-producing beta cells in people with type 1 diabetes.

Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatric Diabetes Units in England and Wales has increased by over 50%. We’re calling on the ...

Everything you need to know about type 2 diabetes remission. Find out what type 2 diabetes remission is, how it works, and what the benefits are.

UPDATE, 22 MAY 2024: We now have new information on the amount of people living with the diabetes, and for more information you can visit our guide on diabetes statistics. The number of people living ...

We take a look at some of the exciting diabetes research developments announced in October, and what the findings could mean for people living with or affected by diabetes.

We're going to explore whether an intermittent fasting diet can help you put your type 2 diabetes into remission. What are intermitten ...

Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...